Skip to content
All authors

Adrian Mercer

Metabolic Pharmacology Editor

Metabolic Science & Peptide Pharmacology

NovaEvum Research Editorial

Education

  • Biochemistry, University of Toronto
  • Pharmacology, Harvard University

Adrian Mercer covers metabolic pharmacology, peptide receptor signalling and emerging developments in multi-receptor agonist research for NovaEvum Research Editorial.

This specialization examines GLP-1, GIP, glucagon and related metabolic pathways, with particular attention to the molecular mechanisms underlying investigational compounds.

These articles evaluate peer-reviewed findings, experimental methods and emerging developments in metabolic science. The coverage evaluates relevant peer-reviewed literature from academic research communities, including Harvard University, the University of Toronto, Yale University and other international centres of metabolic research.

Topics covered

  • Retatrutide
  • Tirzepatide
  • Semaglutide
  • GLP-1
  • GIP
  • Glucagon
  • Metabolic receptors
  • Triple-receptor agonists

Research categories

University references in NovaEvum Research Editorial describe institutions whose published scientific literature may be examined in our editorial coverage. These references do not imply that NovaEvum or its authors are affiliated with, endorsed by, or collaborating with those institutions.

33 articles under this name